1.45BMarket Cap-8916P/E (TTM)
7.500High7.290Low2.28MVolume7.390Open7.190Pre Close16.90MTurnover1.22%Turnover RatioLossP/E (Static)193.01MShares7.50052wk High3.58P/B1.40BFloat Cap3.33052wk Low--Dividend TTM187.36MShs Float48.457Historical High--Div YieldTTM2.92%Amplitude1.470Historical Low7.419Avg Price1Lot Size
Brookdale Senior Living Stock Forum
ColumnsToday's Pre-Market Stock Movers: AAL, ZS, DICE, Crude and More
In reaction to earnings/guidance:
• $New Relic(NEWR.US)$ +3.8% (guidance),$American Airlines(AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
ColumnsToday's pre-market stock movers: PTON, PEP, NVAX, GPS and more
• $Canoo(GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel(WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
ColumnsToday's pre-market stock movers: NIO, NVAX, TSLA, SIG and more
• $Signet Jewelers(SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries(OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma(BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif(GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals(OLMA.US)$ +4.3% (an...
Stocks making the biggest moves after the bell: Avis Budget, Arista Networks & more
$Arista Networks(ANET.US)$ — Shares of Arista Networks popped more than 8% on the back of better-than-expected quarterly results. The company posted an adju...
No comment yet